immune system
• following antigen challenge (NP-Ficoll or NP-KLH) fewer T1 and T2 type B cells are observed in spleen
|
• following antigen challenge (NP-Ficoll or NP-KLH) fewer T1 and T2 type B cells are observed in spleen
|
• following antigen challenge (NP-Ficoll or NP-KLH) fewer T3 cells are observed in spleen
|
• following antigen challenge (NP-Ficoll or NP-KLH) percentage of immature B cells in bone marrow is increased as compared to control
|
• following antigen challenge (NP-Ficoll or NP-KLH)
|
• decrease in IgG1-producing cells in bone marrow from unimmunized mice; these cells may represent either plasma cells or memory B cells
|
• 4 fold decrease in LPS-treated B220loCD138+ splenic B cells
• decline in CD138+ cells in immunized mice
|
• following antigen challenge (NP-Ficoll or NP-KLH) percentage of recirculating B cells in bone marrow is increased as compared to control
|
• following antigen challenge (NP-Ficoll or NP-KLH)
|
• 2 fold decrease in serum levels of secreted IgM, IgG1, IgA and all other IgG isotopes is found in naive mice as compared to controls
|
• specific antibody responses are impaired for both T cell dependent and independent antigens
• mice immunized with NP-Ficoll exhibit less anti-NP antibody of the IgM, IgG2b and IgG3 isotypes
• mice immunized with NP-KLH exhibit less anti-NP antibody of the IgM, IgG1, IgG2c and IgG3 isotopes
• following restimulation, recall response is less than controls
|
hematopoietic system
• following antigen challenge (NP-Ficoll or NP-KLH) fewer T1 and T2 type B cells are observed in spleen
|
• following antigen challenge (NP-Ficoll or NP-KLH) fewer T1 and T2 type B cells are observed in spleen
|
• following antigen challenge (NP-Ficoll or NP-KLH) fewer T3 cells are observed in spleen
|
• following antigen challenge (NP-Ficoll or NP-KLH) percentage of immature B cells in bone marrow is increased as compared to control
|
• following antigen challenge (NP-Ficoll or NP-KLH)
|
• decrease in IgG1-producing cells in bone marrow from unimmunized mice; these cells may represent either plasma cells or memory B cells
|
• 4 fold decrease in LPS-treated B220loCD138+ splenic B cells
• decline in CD138+ cells in immunized mice
|
• following antigen challenge (NP-Ficoll or NP-KLH) percentage of recirculating B cells in bone marrow is increased as compared to control
|
• following antigen challenge (NP-Ficoll or NP-KLH)
|
• 2 fold decrease in serum levels of secreted IgM, IgG1, IgA and all other IgG isotopes is found in naive mice as compared to controls
|
cellular
• ER found in LPS-treated B220loCD138+ cells is dilated and fragmented
|